IDELVION 500 UNIT
COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) : 500 UNIT · DIN 02451344 · CSL BEHRING CANADA INC
Health Canada status: APPROVED
What is IDELVION?
IDELVION 500 UNIT contains COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) : 500 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02451344, held by CSL BEHRING CANADA INC, supplied as KIT ; POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 26-Jan-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02451344 |
|---|---|
| Brand name | IDELVION |
| Generic / active ingredient | COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) : 500 UNIT |
| Manufacturer | CSL BEHRING CANADA INC |
| Strength | 500 UNIT |
| Dosage form | KIT ; POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Schedule D |
| ATC code | B02BD04 COAGULATION FACTOR IX |
| AHFS class | 20:28.16 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 26-Jan-2016 |
What can be used instead?
Other Canadian products sharing ATC code B02BD04 COAGULATION FACTOR IX. 16 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALPROLIX | 1000 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422921 |
| ALPROLIX | 2000 UNIT | POWDER FOR SOLUTION ; KIT | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422948 |
| ALPROLIX | 3000 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422956 |
| ALPROLIX | 500 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422913 |
| BENEFIX | 1000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293781 |
| BENEFIX | 2000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293803 |
| BENEFIX | 3000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02392984 |
| BENEFIX | 500 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293773 |
| IMMUNINE VH | 720 UNIT / 5 ML | POWDER FOR SOLUTION | TAKEDA CANADA INC | MARKETED | DIN 02206021 |
| REBINYN | 1000 UNIT | POWDER FOR SOLUTION | NOVO NORDISK CANADA INC | MARKETED | DIN 02470268 |
Who else supplies COAGULATION FACTOR IX worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COAGULATION FACTOR IX appears in 109 registered pack listings across 5 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.